Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 4Myelodysplastic Syndromes 3Triple Negative Breast Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Lymphoma 2Leukemia 2Hematologic Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Cardiotoxicity 2Carcinoma in Situ 2Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Peritoneal Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1

Interventions

Social Determinants of Health 2Electrocardiography 2Echocardiography 2zanubrutinib 1sofosbuvir-velpatasvir drug combination 1acalabrutinib 1Vascular Stiffness 1Standard of Care 1Restraint, Physical 1Referral and Consultation 1Quality of Life 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Physical Conditioning, Human 1Patient Navigation 1Nutrition Assessment 1Methods 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hematologic Tests 1Health Information Exchange 1Geritol 1Fish Oils 1Fatty Acids, Omega-3 1Ethanol 1Educational Status 1Early Intervention, Educational 1Diet, Mediterranean 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Electrocardiography × 1 year × Clear all
NCT05201014 2025-09-05

CASCADE

Mayo Clinic

Active not recruiting
112 enrolled

Cardiovascular Diseases, Neoplasms

NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡